Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients [NA]
This clinical trial compared 4-liter polyethylene glycol solution to 2-liter polyethylene glycol with ascorbic acid for bowel preparation in…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Canadian Active & Maintenance Modified Pentasa Study [Phase 3]
A Phase 3 Canadian trial evaluating active and maintenance therapy with Pentasa in Ulcerative Colitis has completed and posted results in 20…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis
A completed clinical trial evaluated surgical reconstruction for patients with ulcerative colitis and primary sclerosing cholangitis.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Development of Dysplasia in the Pelvic Pouch in Patients With Ulcerative Colitis (UC) and Risk Factors [NA]
This clinical trial update reports on the development of dysplasia in the pelvic pouch among patients with ulcerative colitis and highlights…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Trial of Chinese Prescription on Ulcerative Colitis [NA]
A completed clinical trial evaluating a traditional Chinese medicine prescription for ulcerative colitis, conducted by Shanghai University o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-04-05FDA Approved: INFLECTRA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved INFLECTRA (infliximab-dyyb) as a biosimilar to infliximab for multiple autoimmune diseases, expanding access to a biologic ther…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of tralokinumab in patients with active, moderate-to-severe ulcerative colitis; results we…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Harmonic ACE®+7 Shears in Laparoscopic Colectomy [Phase 4]
Phase 4 clinical trial evaluating Harmonic ACE+7 Shears for use in laparoscopic colectomy has completed, with results posted in 2016.
-
FDA approval · 2016-03-24FDA Approved: MESALAMINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for mesalamine submitted by ANI Pharmaceuticals, Inc. This action supplements the existing approval …
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients
This completed clinical trial assessed how different information sources influence knowledge and anxiety among patients with inflammatory bo…
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD.
This update describes the IBDSL Biobank Project, which investigates molecular markers for diagnosing inflammatory bowel disease and predicti…
-
CLINICAL_TRIALS research · 2016-03-09Clinical Trial Update: Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Clinical trial update on anal human papillomavirus in inflammatory bowel disease, including ulcerative colitis and Crohn's disease, complete…
-
FDA approval · 2016-03-08FDA Approved: BUDESONIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a generic budesonide product under an Original Application (ANDA 204548) for Teva Pharmaceuticals USA, Inc. This marks the appr…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis Disease [NA]
Update on a Medtronic PillCam IBD capsule endoscopy trial evaluating visualization of colon lesions in ulcerative colitis; the study status …
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis [Phase 2]
Phase 2 study evaluating the safety and potential clinical benefit of MultiStem in adults with moderate to severe ulcerative colitis has com…
-
CLINICAL_TRIALS research · 2016-02-23Clinical Trial Update: Bio-enhanced Curcumin as an Add-On Treatment in Mild to Moderate Ulcerative Colitis [Phase 3]
A Phase 3 clinical trial is evaluating bio-enhanced curcumin as an add-on treatment for mild to moderate ulcerative colitis.
-
CLINICAL_TRIALS research · 2016-02-23Clinical Trial Update: Bio-enhanced Curcumin as an Add-on Treatment in Maintaining Remission of Ulcerative Colitis [Phase 3]
A Phase 3 clinical trial is evaluating bio-enhanced curcumin as an add-on to maintain remission in ulcerative colitis. The current status of…
-
FDA approval · 2016-02-22FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for Simponi Aria (golimumab) from Janssen Biotech, Inc., under BLA125433, to update the product …
-
CLINICAL_TRIALS research · 2016-02-19Clinical Trial Update: Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND) [NA]
A clinical trial update describing the use of NBi to assess luminal inflammation in ulcerative colitis; current trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis [Phase 3]
A Phase 3 trial comparing curcumin added to 5-aminosalicylate therapy versus 5-ASA alone for mild to moderate ulcerative colitis has complet…
-
CLINICAL_TRIALS research · 2016-02-08Clinical Trial Update: Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative Colitis
A clinical trial evaluating confocal laser endomicroscopy as a method to assess mucosal healing in ulcerative colitis.
-
FDA approval · 2016-02-05FDA Approved: BALSALAZIDE DISODIUM — Supplemental Application (Apotex Corp.)
FDA approved a supplemental ANDA for balsalazide disodium by Apotex Corp., clearing regulatory authorization for this generic ulcerative col…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Adalimumab in the Treatment of Chronic Pouchitis [Phase 3]
Phase 3 trial update shows completion of a study evaluating adalimumab for chronic pouchitis in patients with ulcerative colitis. The snippe…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF
This clinical trial update examines factors that predict non-response and loss of response to anti-TNF therapy in patients with inflammatory…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis
A completed clinical trial from Odense University Hospital evaluated scintigraphic imaging to assess ileal pouch-anal anastomosis function i…